We retrospectively analyzed the relationship between clinicopathological characteristics including expression of the PD1/PD-L1 axis and tumor response in 7 advanced and unresectable ICC cases with HBV infection and treated with anti-PD1 immunotherapy. This evidence concerns the gene PDCD1 and intrahepatic cholangiocarcinoma.